ArticleTobacco prevention & cessation2026
Acute respiratory and ocular effects of electronic cigarettes: A pre-post experimental study in healthy users.
Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe use of electronic cigarettes (ECs) has increased alarmingly among young people, often perceived as a safer alternative to conventional tobacco. Studies demonstrating that these are not harmless products are essential to raise awareness of their potential health risks.
methodsA pre-post exposure experimental study was conducted between March and June 2024 at Virgen de la Victoria University Hospital, Málaga, Spain, in 40 healthy regular EC users aged ≥18 years. Respiratory parameters (FeNO, spirometry, oscillometry) and ophthalmological assessments (Schirmer test, Optical Coherence Tomography, and Pentacam) were evaluated before and after acute EC exposure (40-60 inhalations).
resultsFollowing acute exposure, a statistically significant decrease in FeNO was observed from 21.88 ± 22.01 to 18.05 ± 18.08 ppb (p=0.019), particularly in non-smokers (p=0.003), suggesting an airway inflammatory response. In dual users, a significant increase in pulmonary resistance from 0.21 ± 0.36 to 0.35 ± 0.48 kPa/L∙s (p=0.028) was detected. At the ocular level, the Schirmer test showed reduced tear secretion in 47.5% of participants. Additionally, significant changes were found in macular flow density (p=0.024) and inferior macular choroidal thickness (p=0.015), suggesting a possible retinal hemodynamic alteration.
conclusionsAcute use of ECs induces measurable changes in both respiratory function and ocular parameters. These findings underscore the need to raise awareness about the potential adverse effects of vaping and highlight the importance of further research into its long-term consequences.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.